Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.

I achieved my dreams of becoming a veterinarian and growing my family, all while navigating highs and lows with my cystic fibrosis.

A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis CFTR modulator therapy.

Growing older with CF is an unexpected, sometimes miraculous, and often daunting journey. But for all the challenges it brings, it also means we are redefining what it means to live with CF.

Percent-predicted FEV1 measured before pregnancy did not fall 1 year after in women with highly effective cystic fibrosis ...

In her new, autobiographical short film, Ward explores her deep connection to the sea and the ways in which the ocean, and ...

Yvonne Hughes, 51, from Clydebank in West Dunbartonshire, has lived with cystic fibrosis (CF) – a condition which causes ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a biotechnology company focusing on developing and commercializing therapies for treating cystic fibrosis (CF). The one-month return of Vertex ...

FRESNO, Calif. (KFSN) -- Cystic Fibrosis is a genetic disorder that affects the lungs, digestive system and other organs. Babies are screened for it when they are born. Now, those living with the ...

Munich, Germany – April 9, 2025-- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced its ...

First-ever use of Ebenbuild’s Twinhale technology in idiopathic pulmonary fibrosis lung models Trial results published in Nature Communications Munich, Germany – April 9, 2025-- Ebenbuild ...

This leads to a thick, sticky mucus that gets coated on the lungs and other parts of the body, making it not only hard for people to breathe but also more prone to infections. As a cure has not yet ...